M2 Presswire - Only Eli Lillys Symbyax and AstraZenecas Seroquel have Received FDA Approval for Treatment of Bipolar Depression.
Most Popular
5 Regular Mistakes In Public Speaking
Public Speaking: 7 Secrets Of Great Public Speakers
10 Jobs That Pay $30 An Hour
13 Job Interview Mistakes To Avoid
3 Questions No Job Seeker Ever Wants To Be Asked?
> M2 PRESSWIRE-5 April 2007-Research and Markets: Only Eli Lillys Symbyax and AstraZenecas Seroquel have Received FDA Approval for Treatment of Bipolar Depression.(C)1994-2007 M2 COMMUNICATIONS LTD RDATE:05042007 Dublin: Research and Markets (http://www.researchandmarkets.com/reports/c53480) has announced the addition of the Decision Resources, Inc report: Bipolar Disorder: Can Competitive Advantage Be Established in a Challenging Market? to their offering A poorly understood, complex disease that involves a number of neurotransmitters, bipolar disorder presents several …
Read the rest of this article with a Free Trial at HighBeam Research.
